The role of DAB2IP in androgen receptor activation during prostate cancer progression-Reference-Cited by-同舟云学术

The role of DAB2IP in androgen receptor activation during prostate cancer progression

Published:2013-04-22 Issue:15 Volume:33 Page:1954-1963
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Wu K,Liu J,Tseng S-F,Gore C,Ning Z,Sharifi N,Fazli L,Gleave M,Kapur P,Xiao G,Sun X,Oz O K,Min W,Alexandrakis G,Yang C-R,Hsieh C-L,Wu H-C,He D,Xie D,Hsieh J-T

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2013143.pdf

Reference49 articles.

1. Huggins C, Hodges CV . Studies on prostatic cancer I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate (Reprinted from Cancer Res, vol 1, pg 293-297, 1941). J Urol 2002; 167: 948–951.

2. Heinlein CA, Chang CS . Androgen receptor in prostate cancer. Endocr Rev 2004; 25: 276–308.

3. Feldman BJ, Feldman D . The development of androgen-independent prostate cancer. Nat Rev Cancer 2001; 1: 34–45.

4. Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinanen R, Palmberg C et al. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 1995; 9: 401–406.

5. McKenna NJ, Lanz RB, O'Malley BW . Nuclear receptor coregulators: Cellular and molecular biology. Endocr Rev 1999; 20: 321–344.

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update on the tumor-suppressive functions of the RasGAP protein DAB2IP with focus on therapeutic implications;Cell Death & Differentiation;2024-06-20

2. The scaffold protein disabled 2 (DAB2) and its role in tumor development and progression;Molecular Biology Reports;2024-06-01

3. Disabled-2, a versatile tissue matrix multifunctional scaffold protein with multifaceted signaling: Unveiling its potential in the cancer battle;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-03-19

4. The Tumor Suppressor DAB2IP Is Regulated by Cell Contact and Contributes to YAP/TAZ Inhibition in Confluent Cells;Cancers;2023-06-27

5. Tumour‐suppressive role and clinical application of DAB2IP in triple‐negative breast cancer;Clinical and Translational Discovery;2022-12-30